| Product Code: ETC356004 | Publication Date: Aug 2022 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pharmaceutical glass packaging market import shipment depicted a steady growth trajectory from 2020 to 2024, with a notable CAGR of 10.0 over the period. The market exhibited accelerated expansion between 2023 and 2024, with a growth rate of 20.1, indicating increasing momentum and a flourishing trend in the sector.
The India pharmaceutical glass packaging market was valued at USD 818 million in 2025 and is projected to grow at a compound annual growth rate of 8.3% due to rising demand for hygienic packaging materials over plastic ones owing to its superior barrier properties against water vapor transmission as well as moisture absorption making it suitable for medicines & drugs storage. Additionally, the increasing awareness about environmental protection coupled with government regulations on reducing single-use plastics will also help drive the demand for pharma grade quality glass containers in India.
The pharmaceutical glass packaging market in India is experiencing robust growth due to the expanding pharmaceutical industry. Glass packaging is favored for its inertness, ensuring the integrity and stability of medicines and drugs. With the increasing prevalence of chronic diseases and the growing healthcare infrastructure, there is a rise in the consumption of pharmaceutical products, leading to higher demand for glass packaging. Moreover, the stringent regulations and quality standards set by regulatory authorities have mandated the use of glass containers for certain drugs, further propelling market growth. Additionally, the shift towards eco-friendly and sustainable packaging materials has augmented the adoption of glass packaging in the pharmaceutical sector.
The pharmaceutical glass packaging market in India is witnessing robust growth primarily due to the expanding pharmaceutical industry. Glass packaging is favored for its inertness, ensuring the integrity and stability of medicines and drugs. With the increasing prevalence of chronic diseases and the growing healthcare infrastructure, there is a rise in the consumption of pharmaceutical products, leading to higher demand for glass packaging. Moreover, the stringent regulations and quality standards set by regulatory authorities have mandated the use of glass containers for certain drugs, further propelling market growth. Additionally, the shift towards eco-friendly and sustainable packaging materials has accelerated the adoption of glass packaging in the pharmaceutical sector.
The pharmaceutical glass packaging market in India experienced both challenges and opportunities during the COVID-19 pandemic. The demand for pharmaceuticals surged due to the healthcare crisis, leading to increased production and distribution of medicines and vaccines. This, in turn, drove the demand for glass containers for pharmaceutical packaging. However, the industry faced disruptions in supply chains and transportation, impacting the timely delivery of glass packaging materials. The lockdowns and safety measures also affected the workforce in manufacturing facilities. Despite the challenges, the market witnessed positive growth as the pharmaceutical industry became a priority for the government and healthcare authorities. The focus on vaccine distribution further accelerated the demand for high-quality and reliable glass containers. The pharmaceutical glass packaging industry adapted to the new normal with enhanced safety measures and digitization to ensure continued operations and meet the rising demand for essential healthcare products.
The India pharmaceutical glass packaging market features key players such as SGD Pharma, Schott AG, Piramal Glass, Nipro PharmaPackaging, and Triveni Polymers Pvt. Ltd. These companies are significant providers of glass containers and vials for pharmaceutical packaging. They adhere to strict quality standards and provide specialized solutions for storing and transporting medicines and vaccines. With a focus on safety, reliability, and compliance with pharmaceutical regulations, these key players play a crucial role in ensuring the integrity and efficacy of pharmaceutical products in the India market.
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here